- Home
- SNOW vs EW Comparison
SNOW vs EW Comparison
Compare SNOW & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOW
- EW
- Stock Information
- Founded
- SNOW 2012
- EW 1958
- Country
- SNOW United States
- EW United States
- Employees
- SNOW N/A
- EW N/A
- Industry
- SNOW Computer Software: Prepackaged Software
- EW Industrial Specialties
- Sector
- SNOW Technology
- EW Health Care
- Exchange
- SNOW Nasdaq
- EW Nasdaq
- Market Cap
- SNOW 52.4B
- EW 42.5B
- IPO Year
- SNOW 2020
- EW 2000
- Fundamental
- Price
- SNOW $173.51
- EW $69.97
- Analyst Decision
- SNOW Buy
- EW Buy
- Analyst Count
- SNOW 39
- EW 21
- Target Price
- SNOW $186.92
- EW $78.48
- AVG Volume (30 Days)
- SNOW 4.4M
- EW 4.6M
- Earning Date
- SNOW 02-26-2025
- EW 02-04-2025
- Dividend Yield
- SNOW N/A
- EW N/A
- EPS Growth
- SNOW N/A
- EW 193.69
- EPS
- SNOW N/A
- EW 6.89
- Revenue
- SNOW $3,414,325,000.00
- EW $6,314,900,000.00
- Revenue This Year
- SNOW $30.55
- EW N/A
- Revenue Next Year
- SNOW $22.95
- EW $1.06
- P/E Ratio
- SNOW N/A
- EW $10.16
- Revenue Growth
- SNOW 30.28
- EW 24.02
- 52 Week Low
- SNOW $107.13
- EW $58.93
- 52 Week High
- SNOW $237.72
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- SNOW 64.73
- EW 37.80
- Support Level
- SNOW $164.39
- EW $68.24
- Resistance Level
- SNOW $165.45
- EW $72.10
- Average True Range (ATR)
- SNOW 5.31
- EW 1.58
- MACD
- SNOW 0.80
- EW -0.62
- Stochastic Oscillator
- SNOW 88.50
- EW 24.30
About SNOW Snowflake Inc.
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.